<DOC>
	<DOCNO>NCT00036062</DOCNO>
	<brief_summary>The purpose study determine whether sivelestat reduce amount time patient must spend ventilator and/or increase chance survival patient acute lung injury .</brief_summary>
	<brief_title>A Phase II Study Determine Efficacy Safety Sivelestat Subjects With Acute Lung Injury</brief_title>
	<detailed_description>Acute lung injury often develop result severe infection , sepsis , severe injury , inhalation foreign substance lung , pneumonia . The tissue blood vessel lungs become inflamed , body receive enough oxygen . Patients condition place ventilator assist breathing . Patients enter study randomly assign one two treatment group : sivelestat group placebo group . Once enter study , patient monitor 6 month .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Sivelestat</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Inclusion Criteria show evidence acute lung injury mechanical ventilation Exclusion Criteria undergone certain organ transplant severe underlie medical problem unlikely survive pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Sivelestat</keyword>
	<keyword>acute lung injury</keyword>
</DOC>